Galectin Therapeutics Inc. Common Stock (NASDAQ: GALT) last traded at $3.94, up 8.24% on the session. The quote above updates while this page is open; the figures below are drawn from Galectin Therapeutics Inc. Common Stock’s own filings and are restated only when a new one is published.
Galectin Therapeutics Inc. Common Stock trades on NASDAQ under the ticker GALT. Its market capitalisation is $397.35 million.
Valuation measures for Galectin Therapeutics Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $397.35M |
|---|---|
| Enterprise value | $535.76M |
| Beta | 0.81 |
Trailing-twelve-month figures tagged in Galectin Therapeutics Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) | -$27.84M |
|---|---|
| Cash |
|---|
| $13.27M |
Range and volume for GALT over the past 52 weeks.
| 52-week high | $7.13 |
|---|---|
| 52-week low | $2.03 |
| Volume | 156.5K |
| Average volume | 379.7K |
| Previous close | $3.64 |
Invest a chosen dollar amount in Galectin Therapeutics Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell GALT.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.